Zimbabwe has declined a major American healthcare agreement worth $367m (£272m) over five years over Washington's demand for confidential biological samples.
The decision came to light after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesman later explained that the United States was demanding access to health data for scientific study and commercial gain but refused to share the resulting advantages from any future vaccines.
"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more negotiations to secure a deal suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Context
This development follows a comparable situation in neighbouring Kenya, where a high court suspended a related deal with the US following legal challenges were raised about the safety of Kenyans' medical information.
Since resuming office recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
The agency had overseen assistance for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking government-to-government deals to enhance transparency and responsibility.
As per statements, Sixteen African countries have to date signed similar health pacts, representing more than $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, with no corresponding guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"Put simply, our country would provide the raw materials for scientific discovery without any assurance that the final treatments would be accessible to our people if a new pandemic arise."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were upending frameworks previously set up via the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.
"This mechanism is designed to guarantee that when a nation contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "are not meant as opposition to America," he added.
"We encourage ongoing discussions with our American counterparts on how subsequent collaboration could be arranged in a way that honours the sovereignty and dignity of both nations."
Medical Community Response
A leading public health body expressed it understood the official position, but urged that talks must proceed given that much of the nation's Aids initiatives relied on international support.
"In cases where specific concerns arise, such as those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group said.
The halted deal emphasises the ongoing tensions between receiving crucial international aid and safeguarding national sovereignty in an increasingly data-driven world.